RALEIGH, N.C., Dec. 10, 2025 /PRNewswire/ -- Lumexa Imaging Holdings, Inc. ("Lumexa Imaging") announced today the pricing of its initial public offering of 25,000,000 shares of its common stock, par value $0.001 per share (the "Common Stock"), at a price to the public of $18.50 per share of Common Stock. In connection with the offering, Lumexa Imaging has granted the underwriters a 30-day option to purchase up to an additional 3,750,000 shares of its Common Stock. The Common Stock is expected to begin trad ...

IPO基本信息 - 公司计划以每股17-20美元的价格发行2500万股股票进行首次公开募股 [1] - 此次IPO计划筹资约4.63亿美元 [1] - 公司计划在纳斯达克上市，股票代码为"LMRI" [1] 公司业务与运营 - 公司是一家全国性的门诊诊断影像服务提供商，总部位于北卡罗来纳州 [1] - 公司通过全资运营及与医疗系统合资合作的模式，在美国13个州运营着184家诊疗中心 [1] - 公司提供包括磁共振、计算机断层扫描、正电子发射断层显像、X光、超声及乳房X光检查在内的各类先进及常规影像检查服务 [1] 公司发展历程与规模 - 公司由Charlotte Radiology与投资机构Welsh, Carson, Anderson & Stowe于2018年联合创立 [1] - 成立之初仅拥有20家中心，后通过20次收购及41家全新门店的开设实现规模扩张 [1] - 公司已构建多元化转诊网络，合作医师覆盖2.9万余家医疗机构，总人数约10万名 [1] - 在截至2025年9月30日的12个月销售额为10亿美元 [1]

公司上市计划 - Lumexa Imaging 计划在美国进行首次公开募股，目标估值超过18.9亿美元 [1] 公司股权背景 - 公司由私募股权公司 Welsh Carson 支持 [1]

Donovan Jones is an IPO research specialist with 15 years of experience identifying opportunities for high quality IPOs.He also leads the investing group IPO Edge, which offers actionable information on growth stocks through first-look IPO filings, previews on upcoming IPOs, an IPO calendar for tracking what’s on the horizon, a database of U.S. IPOs, and a guide to IPO investing to walk you through the entire IPO lifecycle - from filing to listing to quiet period and lockup expiration dates. Learn moreAnaly ...